<DOC>
	<DOCNO>NCT00857584</DOCNO>
	<brief_summary>Prospective , open-label , control ( active comparator ) , randomize study 8 week follow-up evaluation efficacy extend release quetiapine ( quetiapine XR ) versus Sertraline addition previous mood stabilizer treatment ( lithium valproate stable clinically therapeutic blood level ) treatment adult bipolar depression . This multicentric study feature two site Spain .</brief_summary>
	<brief_title>Quetiapine XR Versus Sertraline Acute Bipolar Depression add-on Therapy</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Adult ambulatory patient diagnose bipolar disorder I II , current depressive episode ( DSMIVTR 4ª Ed : 296.5x 296.89 code ) Have treat one mood stabilizer ( lithium valproate ) optimal stable dos least previous 4 week randomization Hamilton Depression Rating Scale ( HDRS17 ) total score ≥ 20 Young Mania Rating Scale ( YMRS ) total score ≤ 14 screen randomization visit Informed consent sign Patients axis I II Diagnostic Statistical Manual Mental Disorders , 4th edition , text revision ( DSMIVTR ) diagnose different bipolar disorder I II Length current depressive episode less 2 week 12 month Having treat one mood stabilizer mood stabilizer Lithium valproate , antidepressant , antipsychotic CP4503A inductor/inhibitor within 7 day period prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>Bipolar depression</keyword>
	<keyword>quetiapine</keyword>
	<keyword>sertraline</keyword>
</DOC>